Capsule

PANTHERx®Rare Selected by Edenbridge Pharmaceuticals as Specialty Pharmacy for Yargesa® (miglustat 100 mg capsules)

Retrieved on: 
Monday, April 1, 2024

Yargesa® is a glucosylceramide synthase inhibitor that exerts its effects through a process called substrate reduction therapy.

Key Points: 
  • Yargesa® is a glucosylceramide synthase inhibitor that exerts its effects through a process called substrate reduction therapy.
  • Through this process, Yargesa® reduces the buildup of harmful glycosphingolipids and symptoms of the disease.
  • This accumulation leads to manifestations including but not limited to enlarged spleen or liver, hepatomegaly, anemia, thrombocytopenia, and bone pain.
  • "We appreciate Edenbridge Pharmaceuticals' commitment to making a difference in the lives of patients with Type 1 Gaucher disease.

Halo Appliances Award-Winning Capsule X Vacuum Now Available for Purchase on Walmart.com

Retrieved on: 
Monday, April 1, 2024

BOCA RATON, Fla., April 1, 2024 /PRNewswire/ -- Halo Appliances, a pioneer in innovative cleaning technology, is thrilled to announce that the Capsule X cordless vacuum bundle is now available for purchase exclusively on Walmart.com.

Key Points: 
  • BOCA RATON, Fla., April 1, 2024 /PRNewswire/ -- Halo Appliances, a pioneer in innovative cleaning technology, is thrilled to announce that the Capsule X cordless vacuum bundle is now available for purchase exclusively on Walmart.com.
  • Paul Bagwell, founder, inventor, and CEO of Halo Appliances, stated, "Launching the Halo Capsule X in the U.S. market marks a significant step forward in transforming home cleaning.
  • The Capsule X reflects Halo Appliances' dedication to promoting a cleaner and more sustainable future.
  • To explore the revolutionary Capsule X and discover more about Halo Appliances' innovative solutions, visit www.haloappliances.com .

West Wolf Medicinals Introduces New Product Line -- Single Ingredient Mushroom Capsule Extracts

Retrieved on: 
Thursday, March 21, 2024

The All-New Single Ingredient Mushroom Extract Capsules allow users to enjoy highly potent ancient medicine in the palm of their hand.

Key Points: 
  • The All-New Single Ingredient Mushroom Extract Capsules allow users to enjoy highly potent ancient medicine in the palm of their hand.
  • Makers of High Potency Mushroom Extract Powder Blends, West Wolf Medicinals , is proud to now offer their always organic, 3rd party-tested mushroom powders in an easy-to-swallow capsule.
  • West Wolf Medicinals introduces the four most popular medicinal mushrooms, available at one of the highest potencies on the market.
  • Mushroom farmer Nicole Wolf started the company after finding it difficult to source potent organic mushroom extracts to help with the symptoms of perimenopause.

Verb Biotics Announces Data from Preclinical Studies to Support Foundational Gut Microbiome Health from Newly Launched Keystone Postbiotic™

Retrieved on: 
Tuesday, March 19, 2024

BOSTON, March 19, 2024 /PRNewswire/ -- Verb Biotics, a microbiome health ingredient company, today announced preliminary preclinical data from their newly launched Keystone Postbiotic™, a foundational gut microbiome solution to help support and strengthen gut microbiome health.

Key Points: 
  • BOSTON, March 19, 2024 /PRNewswire/ -- Verb Biotics, a microbiome health ingredient company, today announced preliminary preclinical data from their newly launched Keystone Postbiotic™, a foundational gut microbiome solution to help support and strengthen gut microbiome health.
  • Verb Biotics has conducted thorough in-vitro and preliminary human studies to understand how Keystone Postbiotics' deliberately chosen active components contribute to maintaining a robust gut microbiome and a well-regulated immune response.
  • The preclinical data contributed to the decision by Verb Biotics to commence human clinical studies in January 2024 to evaluate the potential support of foundational gut microbiome health by Keystone Postbiotic™.
  • Keystone Postbiotic™ combines strains, grains, and botanicals to deliver functional redundancy to support foundational gut microbiome health.

Halo Appliance Set to Debut its Game-Changing Capsule X Cordless Vacuum Cleaner on Amazon

Retrieved on: 
Thursday, March 14, 2024

BOCA RATON, Fla., March 14, 2024 /PRNewswire/ -- Halo Appliance is excited to announce the upcoming launch of Capsule X, a groundbreaking addition to the cordless vacuum cleaner market, on Amazon.

Key Points: 
  • BOCA RATON, Fla., March 14, 2024 /PRNewswire/ -- Halo Appliance is excited to announce the upcoming launch of Capsule X, a groundbreaking addition to the cordless vacuum cleaner market, on Amazon.
  • Key Features of the Capsule X:
    Award-Winning Innovation: Capsule X redefines excellence in cleaning with its award-winning performance, proving that cordless can be powerful.
  • Solid Warranty Protection: Backed by a 2-year warranty, Halo assures consumers of the durability and quality of their Capsule X purchase.
  • Beyond mere cleaning, the Capsule X is a step towards a cleaner and more eco-conscious future.

Caldic Announces A Strategic Partnership With Celesta To Bring Sleep And Stress Reduction Ingredient Blends To The USA and Canada

Retrieved on: 
Tuesday, March 12, 2024

MISSISSAUGA, ON , March 12, 2024 /PRNewswire-PRWeb/ -- Caldic North America has announced a strategic partnership with Celesta Company LLC, a leading formulator of science-based stress reduction and sleep-promoting ingredient blends. This collaboration will further expand Caldic's portfolio through the introduction of Celesta's proprietary ingredient blends and technologies designed to enhance sleep, mood, and relaxation, including the SlumberMor™ and RnRMor™. This new offering will enable the delivery of value-added solutions and help drive innovation in the food, beverage, snack, and pet food industry. Caif Nutrition – the division of Caldic North America specializing in functional and nutritional ingredients – will market the complementary portfolio in the United States and Canada.

Key Points: 
  • Caldic has entered into a strategic partnership with Celesta, a leading formulator of science-based stress reduction and sleep-promoting ingredients.
  • MISSISSAUGA, ON , March 12, 2024 /PRNewswire-PRWeb/ -- Caldic North America has announced a strategic partnership with Celesta Company LLC, a leading formulator of science-based stress reduction and sleep-promoting ingredient blends.
  • "We are excited to enter into this partnership with the talented team at Caldic", said Dave Lafond, Celesta CEO.
  • Celesta has developed proprietary herbal ingredient blends that target well-being, addressing in particular sleep induction, sleep duration, stress reduction, body recovery, and mood stabilization.

FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA® (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children

Retrieved on: 
Monday, March 11, 2024

NORTHBROOK, Ill., March 11, 2024 /PRNewswire/ -- Astellas Pharma US, Inc.  (TSE: 4503, President: Mark Reisenauer, "Astellas") announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug and pediatric exclusivity to CRESEMBA® (isavuconazonium sulfate) for the treatment of invasive aspergillosis (IA) and invasive mucormycosis (IM) in pediatric patients. On December 8, 2023, CRESEMBA for injection was approved for pediatric patients 1 year of age and older and capsules for pediatric patients 6 years of age and older who weigh 16 kilograms (kg) and greater.  

Key Points: 
  • On December 8, 2023, CRESEMBA for injection was approved for pediatric patients 1 year of age and older and capsules for pediatric patients 6 years of age and older who weigh 16 kilograms (kg) and greater.
  • The FDA grants orphan drug exclusivity to orphan drugs that receive FDA marketing approval.
  • The FDA previously granted orphan drug exclusivity for CRESEMBA in 2015 for the treatment of IA and IM in adults.
  • "Astellas recognizes the importance of addressing significant unmet medical needs, especially for pediatric patients with rare and potentially life-threatening IA and IM infections.

Private companies are exploiting outer space, but the law is struggling to catch up

Retrieved on: 
Wednesday, April 3, 2024

The goal was to deposit human remains on the lunar surface, and to release the content of the capsules in space.

Key Points: 
  • The goal was to deposit human remains on the lunar surface, and to release the content of the capsules in space.
  • NASA’s response was telling: they were unable to check the payloads’ contents, as they belonged to a private company.
  • International law needs to promptly and carefully regulate all space activity in order to safeguard the future of space exploration.

Anthropogenic contamination: the human footprint in space

  • Our species’ space footprint can be divided into two broad categories: evidence of human presence in the form of objects or artefacts (including “space junk”), and the release (intentional or unintentional) of biological substances, such as the scattering of human remains in space by private companies like the Arch Mission Foundation.
  • Article IX of the 1967 Outer Space treaty, which applies to all space activities, states that countries must consider the interests of other states when conducting space operations.
  • Accordingly, they must also take steps to avoid the harmful contamination of outer space, including the Moon and other celestial bodies.

Space accidents

  • In the 2019 Beresheet accident, a privately funded Israeli spacecraft crashed on the Moon during its landing attempt.
  • It allegedly spilled samples of human DNA along with thousands of tardigrades, tiny invertebrate animals able to survive under extreme conditions that are used in experiments to test the limits of survival in outer space.
  • In this instance, the international laws which exist also to protect the lunar environment from contamination were quite easily evaded, raising serious doubts as to space law’s effectiveness.

Gaps in space law

  • Given the intensifying human presence in space, these need to be promptly addressed, especially in the case of novel privately funded activities like space tourism.
  • It is imperative that states adopt or tighten national laws ensuring that all operators, public and private, conduct activities in line with international space law.
  • Importantly, such laws must also ensure that space operators adhere to environmental protection – for example by carrying out environmental impact assessments (EIA) – to avoid creating additional risks to space activity, as is the case with space debris.


Manolis Plionis has been a member of the independent consultant body: European Space Science Committee, for two terms since 2018. Anthi Koskina no recibe salario, ni ejerce labores de consultoría, ni posee acciones, ni recibe financiación de ninguna compañía u organización que pueda obtener beneficio de este artículo, y ha declarado carecer de vínculos relevantes más allá del cargo académico citado.

Withdrawn application: Ongentys, 12/03/2024

Retrieved on: 
Wednesday, April 3, 2024

Fluctuations happen when the effects of the medication wear off and symptoms re-emerge before the next dose is due.

Key Points: 
  • Fluctuations happen when the effects of the medication wear off and symptoms re-emerge before the next dose is due.
  • It contains the active substance opicapone and is available as capsules to be taken by mouth.
  • t
    The application was withdrawn after the European Medicines Agency had evaluated the information from the company and had prepared questions for the company.
  • If you are in a clinical trial and need more information about your treatment, speak with your clinical trial doctor.

Steeped Coffee Announces Investment Opportunity Open to the General Public

Retrieved on: 
Wednesday, February 21, 2024

SANTA CRUZ, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) --  Steeped Coffee, the Certified B Corp revolutionizing coffee with its sustainable, single-serve brewing method, partners with Republic for a public investment opportunity .

Key Points: 
  • SANTA CRUZ, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) --  Steeped Coffee, the Certified B Corp revolutionizing coffee with its sustainable, single-serve brewing method, partners with Republic for a public investment opportunity .
  • Steeped merges ultra-premium taste and sustainability, offering a convenient, machine-free brewing experience with its award-winning Steeped™ Brew Bags.
  • With a double bottom line prioritizing people over profits, Steeped embodies the principles of a Certified B Corp and Public Benefit Corporation.
  • You are invited to learn more about Steeped Coffee's investment opportunity and how you can be a part of its growth story.